Aurinia Pharmaceuticals Stock Hub: LUPKYNIS, PRESERVE, Aritinercept, Kevin Tang and the 2026 Autoimmune Strategy

Aurinia Pharmaceuticals Stock Hub: LUPKYNIS, PRESERVE, Aritinercept, Kevin Tang and the 2026 Autoimmune Strategy

Merlintrader Jul 11, 2026
Compass Pathways Stock Hub 2026: COMP360, Six-Month Phase 3 Data, the Rolling NDA and the Road to a Potential 2027 Launch

Compass Pathways Stock Hub 2026: COMP360, Six-Month Phase 3 Data, the Rolling NDA and the Road to a Potential 2027 Launch

Jul 10, 2026
uniQure (Nasdaq: $QURE) Stock Hub: AMT-130, the FDA Reversal and the Q3 2026 BLA Path

uniQure (Nasdaq: $QURE) Stock Hub: AMT-130, the FDA Reversal and the Q3 2026 BLA Path

Jul 10, 2026
Rocket Pharmaceuticals (Nasdaq: $RCKT) Stock Hub: KRESLADI Approval, Danon Restart and the Cardiovascular Gene Therapy Reset

Rocket Pharmaceuticals (Nasdaq: $RCKT) Stock Hub: KRESLADI Approval, Danon Restart and the Cardiovascular Gene Therapy Reset

Jul 10, 2026

Merlintrader's Daily Briefing

Saturday, July 11, 2026, weekend edition. Wall Street closed a winning week on a firm note: on Friday the S&P 500 rose 0.42% to 7,575.39 and the Nasdaq Composite added 0.29% to 26,281.61, both up more than 1% on the week, while the Dow gained 0.29% to 52,637.01 but finished the week down about 0.5%. The tape was carried by chips, with Nvidia up roughly 4% and Meta about 6%, in a week defined by SK Hynix’s record ~$26.5 billion Nasdaq debut. The focus now shifts to a heavy week ahead: June CPI on Tuesday, July 14, and the start of big-bank earnings the same day, against a still-tense U.S.-Iran backdrop around the Strait of Hormuz.

Wall Street: how the week ended
  • S&P 500— The S&P 500 settled Friday up 0.42% at 7,575.39, capping a gain of more than 1% on the week led by semiconductors.Indices
  • Nasdaq— The Nasdaq Composite rose 0.29% to 26,281.61, also finishing the week higher by more than 1% as megacap tech firmed.Indices
  • Dow— The Dow added 149.60 points, or 0.29%, to 52,637.01, but lagged for the week, slipping about 0.5% as cyclicals underperformed.Indices
  • Breadth— Small caps outperformed into the close and the VIX stayed subdued near 16, signaling calm despite Middle East headlines.Sentiment
The AI-memory trade after SK Hynix
  • SKHY— SK Hynix’s Friday debut, the largest-ever U.S. listing by a foreign company at about $26.5 billion, lifted its value near $1.27 trillion and keeps the AI-memory trade in focus.Chips
  • NVDA— Nvidia climbed about 4% Friday, supporting the S&P 500 as an SK Hynix high-bandwidth-memory customer at the center of the AI supply chain.AI
  • META— Meta jumped about 6% after a broker note flagged AI-infrastructure costs potentially below Wall Street estimates.AI
  • MU— Micron underperformed as investors weighed SK Hynix as a direct HBM competitor even as memory pricing stayed the sector’s swing factor.Chips
The week ahead: CPI and bank earnings
  • CPI— June CPI lands Tuesday, July 14, at 8:30 a.m. ET; headline is seen easing to about 3.7% year over year from 4.2%, with a roughly 0.1% monthly dip.Macro
  • Core— Core CPI is expected to stay sticky at about 0.3% month over month, keeping the disinflation debate alive into the print.Macro
  • Banks— Second-quarter earnings open Tuesday with JPMorgan, Citigroup, Goldman Sachs, Wells Fargo and Bank of America, a first read on consumer credit and trading.Earnings
  • Fed— Fed Chair Kevin Warsh is set to deliver his first semiannual monetary-policy testimony to Congress beginning Tuesday, a key event for rate expectations.Rates
Oil, Iran and the Strait of Hormuz
  • Oil— Crude stayed elevated, with WTI near $72 and Brent above $76, after Washington revoked an Iran oil-sales waiver with a wind-down by July 17.Oil
  • Hormuz— Fresh attacks on vessels transiting the Strait of Hormuz kept a geopolitical risk premium in crude even as equities looked past it.Geopolitics
  • Iran— The U.S.-Iran standoff remains the weekend’s key wildcard, with any escalation or de-escalation likely to set Monday’s tone for oil.Geopolitics
Rates, gold and volatility
  • 10Y— The 10-year Treasury yield finished Friday around 4.56%, holding near recent highs ahead of Tuesday’s inflation data.Rates
  • Gold— Gold eased to about $4,111 an ounce as firmer yields and risk-on sentiment weighed on the metal.Commodities
  • VIX— The VIX held low near 16, reflecting a market willing to fade geopolitical headlines heading into the CPI print.Macro
Earnings season opens
  • Q2— S&P 500 second-quarter earnings are expected to jump about 23% from a year ago, a high bar that frames the coming reports.Earnings
  • Later— Netflix, UnitedHealth and GE Aerospace headline the back half of the week, broadening the read beyond the banks.Earnings
Catalysts and watchlist
  • Setup— With the U.S. data slate empty over the weekend, CPI and the bank prints become the first tests for a market riding a chip-led advance.Watchlist
  • Biotech— Catalyst flow across the small- and mid-cap biotech watchlist is quiet into mid-week; the focus stays on verified PDUFA dates and clinical readouts rather than speculation.Biotech
Bottom line
  • First read— A chip-led week ended firmly: the S&P 500 and Nasdaq closed higher by more than 1%, the Dow lagged, and SK Hynix’s record ~$26.5 billion debut anchored the AI-memory narrative.Bottom Line
  • Second read— Oil stayed elevated on the Iran waiver revocation and Hormuz attacks, but subdued volatility and firm breadth showed markets fading the geopolitics for now.Bottom Line
  • Third read— The week ahead is the real test: June CPI and the opening bank earnings on Tuesday, plus Fed Chair Warsh’s first congressional testimony, will steer rate expectations.Bottom Line
  • Fourth read— For U.S.-focused readers the filter stays on chips and AI-memory names, the big banks, crude and the Iran headlines, and biotech only on verified catalysts.Bottom Line
Read the full Daily Briefing
Listed / exchange-traded biotech focus

Weekly Biotech Catalyst Tracker

Window covered: July 6 → October 6, 2026. Compact homepage grid for FDA decisions, regulatory submissions and major clinical readouts. Tap any ticker box for the detailed catalyst note.

23Active
16FDA / Reg
7Data / BLA
Jul 8Updated
No matching catalyst found. Try another ticker or reset filters.

Most attention-worthy watchlist

$CELC$OTLK$REPL$CAPR$NUVL$RARE$IONS$IMMX$SLN$QURE

Calendar cleanup

Removed from the active three-month board: $PRAX moved to December 27, 2026, $SVRA moved to November 22, 2026, and $CORT is no longer an open July PDUFA because relacorilant / Lifyorli was approved early. Orca-T / Tregzi was approved early, but Orca Bio is private, so it is sector context only.

Educational content only — not investment advice. Verify dates and filings before trading around binary events. Full catalyst calendar FDA SEC EDGAR

Biotech Catalyst Lookup

Type a ticker to get an AI-generated snapshot of the next catalyst (PDUFA, clinical data, regulatory events) with a link to the primary source.

Disclaimer. This content is for educational and informational purposes only. It is not investment advice and not a recommendation to buy or sell any security, in line with CONSOB (Italy) and SEC (USA) guidance. Data is generated by AI from web sources and may contain errors or be out of date — always verify against the linked primary source. Do your own research and consult a licensed advisor. Full disclaimer: merlintrader.com/disclaimer.

Avvertenza. Questo contenuto ha finalità esclusivamente didattiche e informative. Non costituisce consulenza finanziaria né una raccomandazione di acquisto o vendita di alcun titolo, in linea con le indicazioni CONSOB (Italia) e SEC (USA). I dati sono generati dall'AI a partire da fonti web e possono contenere errori o non essere aggiornati — verifica sempre rispetto alla fonte primaria collegata. Fai le tue ricerche e consulta un consulente autorizzato. Disclaimer completo: merlintrader.com/disclaimer.